Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Plasma Cell-free DNA Fragmentomics for Early Detection of Pancreatic Neuroendocrine Tumors and Differential Diagnosis of Solid Pancreatic Tumors

NCT05847855 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05847855
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05847855 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Plasma Cell-free DNA Fragmentomics for Early Detection of Pancreatic Neuroendocrine Tumors and Differential Diagnosis of Solid Pancreatic Tumors
Lead sponsor
Fudan University
Phase
Observational
Overall status
Recruiting
Start date
February 27, 2023
Completion date
June 30, 2026
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic neuroendocrine tumor, solid pancreatic neoplasms